Entrepreneur, Investor, COO of Immix Biopharma Inc., and Head of StartX Med
Ryan Witt leadership, expertise and impact have been recognized by colleagues and industry peers both locally and federally. In 2018, industry trade organization Biocom awarded Ryan with a Catalyst Award; and, in 2014 the federal government of the United States appointed him to the Consumer Empowerment Working Group of the Department of Health and Human Services.
Ryan started his career educating elected federal representatives in the United States around combination medical products, single patient investigational new drugs, and molecular characterization regulatory protocols. Following this, he led high-growth technology startups in healthcare, backed by top venture capitalists and angel investors such as Y Combinator, Yuri Milner, 500 Startups, Rock Health, Charles River Ventures, General Catalyst, and the founder of a top pharmaceutical company, move to their next inflection points. Subsequently, Ryan managed an oncology and anti-inflammatory therapeutics company for over five years - leading it into a phase 1b clinical trial and bringing on additional financing to capitalize the company. The products he has worked on have reached tens of thousands of physicians and millions of patients worldwide.
Currently, Mr. Witt leads StartX Med - a nonprofit community for Stanford's brightest entrepreneurs, consults for UCLA and industry, and is an active member of Tech Coast Angels.